Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 1.38 AUD 1.47% Market Closed
Market Cap: 372.8m AUD

EV/EBITDA
Enterprise Value to EBITDA

-15.9
Current
-3.9
Median
11.9
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-15.9
=
Enterprise Value
379.3m AUD
/
EBITDA
-15.4m USD

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-16.2
2-Years Forward
EV/EBITDA
-42.3
3-Years Forward
EV/EBITDA
16.8